S.Biomedics Co., Ltd.
🇰🇷South Korea
Clinical Trials
5
Active:3
Completed:0
Trial Phases
2 Phases
Phase 1:4
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Not Applicable
1 (20.0%)Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of A9-DPC in SB-PD-001 Study
Not Applicable
Active, not recruiting
- Conditions
- Parkinson's Disease
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06477744
- Locations
- 🇰🇷
Yonsei Universitiy Health System, Severance Hospital, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
Phase 1
Active, not recruiting
- Conditions
- Parkinson's Disease
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT05887466
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet
Phase 1
Recruiting
- Conditions
- Crow's Feet
- Interventions
- Biological: Clusters of Autologous Dermal FibroblastsOther: Placebo
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT04818203
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI
Phase 1
Recruiting
- Conditions
- Spinal Cord Injury, AcuteSpinal Cord Injury at C5-C7 Level With Complete LesionSpinal Cord Injury at C4 Level With Complete Lesion
- Interventions
- Biological: Neural precursor cells derived from human embryonic stem cell line
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT04812431
- Locations
- 🇰🇷
Ajou University Hospital, Suwon, Gyeonggido, Korea, Republic of
🇰🇷Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia
Phase 1
Active, not recruiting
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04661644
News
No news found